Top compounds associated with response to DST


Feature Type Standardized
Nominal ANOVA
mRNA SNS-032 CTRPv2 pan-cancer AAC -0.2 2e-07
mRNA narciclasine CTRPv2 pan-cancer AAC -0.18 3e-07
mRNA clofarabine CTRPv2 pan-cancer AAC -0.16 4e-07
mRNA Topotecan CTRPv2 pan-cancer AAC -0.17 5e-07
mRNA vincristine CTRPv2 pan-cancer AAC -0.16 1e-06
mRNA carboplatin:etoposide (40:17 mol/mol) CTRPv2 pan-cancer AAC -0.16 1e-06
mRNA Nutlin-3 CTRPv2 pan-cancer AAC -0.18 2e-06
mRNA decitabine CTRPv2 pan-cancer AAC -0.14 2e-06
mRNA Compound 23 citrate CTRPv2 pan-cancer AAC -0.18 2e-06
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.17 2e-06
Download CSV